VIE/GXI (VIE/GXI)

Vienna Stock Exchange: VIE/GXI · EUR

€32.0

-0.50 (-1.5%)· Recorded snapshot

Market cap	1.1B
Revenue (ttm)	2.3B
Net income (ttm)	-405.8M
EPS (ttm)	-€11.7
P/E (forward)	16.6x
Volume	538

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.3B
Net income (ttm): -405.8M
EPS (ttm): -€11.7
P/E (forward): 16.6x
Market cap: 1.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E16.6

P25 14.3P50 18.7P75 25.4

Trailing P/En/a

P25 20.4P50 26.7P75 39.7

ROE-32.4

P25 4.8P50 10.6P75 20.1

ROIC1.2

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/GXI indicators

Market & fundamental data

Available fields

195

Groups with data

Currency

EUR

Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Germany
Country code	AT
Earnings date	2026-10-30
Employees	13,301
Employees change	1,386
Employees growth	11.41%
Enterprise value	EUR 3.3B
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-02-28
First seen	2026-05-10
Fiscal year end	November
Founded	1864
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	DE000A0LD6E6
Last earnings date	2026-09-30
Last refreshed	2026-10-30
Market cap	EUR 1.1B
Next earnings date	2026-10-30
Price	EUR 31.98
Price currency	EUR
Sector	Healthcare
SIC code	3220
Stock price date	2026-10-29
Symbol	vie/GXI
Website	https://www.gerresheimer.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	63.3x
Average P/E ratio (3Y)	168.3x
Average P/E ratio (5Y)	105.26x
Earnings yield	-36.74%
EV/EBIT	85.99x
EV/EBITDA	9.39x
EV/Sales	1.42x
FCF / EV yield	-0.09%
FCF yield	-0.28%
Forward P/E	16.55x
P/B ratio	1.12x
P/OCF ratio	4.21x
P/S ratio	0.48x
Price/EBITDA ratio	3.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.65%
EBITDA margin	13.95%
Gross margin	20.96%
Operating margin	1.65%
Pretax margin	-16.58%
Profit margin	-17.51%
Profit per employee	EUR -30,510
Revenue per employee	EUR 174,211
ROA	0.52%
ROA (5Y)	3.21%
ROCE	1.31%
ROE	-32.35%
ROE (5Y)	1.62%
ROIC	1.2%
ROIC (5Y)	5.39%
Tax / revenue	1.03%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	-11.81%
Gross profit growth (Q)	-56.01%
Gross profit growth 3Y	-5.76%
Gross profit growth 5Y	1.95%
Net income growth years	0
OCF growth	42.25%
OCF growth (QoQ)	-72.93%
OCF growth 10Y	3.37%
OCF growth 3Y	15.22%
OCF growth 5Y	1.45%
Operating income growth	-76.61%
Operating income growth 3Y	-42.02%
Operating income growth 5Y	-24.95%
Revenue growth	15.64%
Revenue growth (Q)	-0.77%
Revenue growth (QoQ)	-25.73%
Revenue growth 10Y	5.94%
Revenue growth 3Y	6.76%
Revenue growth 5Y	10.32%
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -264.7M
Depreciation and amortization	EUR 284.9M
EBIT	EUR 38.2M
EBITDA	EUR 323.2M
EPS	EUR -11.75
Financing cash flow	EUR 40.3M
Free cash flow	EUR -3.1M
Gross profit	EUR 485.6M
Income taxes	EUR 23.8M
Investing cash flow	EUR -240.9M
Net borrowing	EUR 43M
Net cash flow	EUR 45.8M
Net income	EUR -405.8M
Operating income	EUR 38.2M
Revenue	EUR 2.3B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.11
Book value per share	EUR 27.69
Debt / EBITDA	6.65
Debt / equity	2.37
Goodwill	EUR 604.5M
Interest coverage	0.46
Long-term assets	EUR 2.8B
Long-term liabilities	EUR 1.9B
Net cash (debt)	EUR -2.2B
Net cash / market cap	-195.82%
Net debt / EBITDA	6.68
Net debt / equity	2.2
Piotroski F-Score	5
Property, plant and equipment	EUR 1.8B
Shareholders' equity	EUR 982.2M
Tangible book value	EUR -49.5M
Tangible book value per share	EUR -1.43
Total assets	EUR 4.4B
Total cash	EUR 167.6M
Total debt	EUR 2.3B
Total liabilities	EUR 3.4B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.5
Current assets	EUR 1.5B
Current liabilities	EUR 1.4B
Current ratio	1.07
Inventory turnover	3.83
Net working capital	EUR 669.8M
Quick ratio	0.29
Working capital	EUR 99.2M
Working capital turnover	-7.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth (3Y)	-68.25%
Dividend growth (5Y)	-49.35%
Dividend growth years	0
Dividend payment date	2025-06-10
Dividend payment years	8
Dividend per share	EUR 0.00
Last dividend	EUR 0.04

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 26.54
1D price change	-1.54%
1M price change	18.18%
1M total return	18.18%
1Y price change	12.05%
1Y return CAGR	12.06%
1Y total return	12.05%
20-day SMA	EUR 30.28
200-day SMA	EUR 25.23
3M price change	19.24%
3M total return	19.24%
3Y price change	-63.88%
3Y return CAGR	-28.48%
3Y total return	-63.43%
50-day SMA	EUR 28.56
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 33.68
52-week high date	2026-10-28
52-week low	EUR 15.40
52-week low date	2026-02-26
5Y price change	-60.15%
5Y return CAGR	-16.12%
5Y total return	-58.46%
6M price change	33.7%
6M total return	33.7%
All-time high	EUR 122.00
All-time high date	2023-09-05
All-time low	EUR 15.40
All-time low date	2026-02-26
Average true range (ATR)	EUR 0.75
Average volume	131.3
Change from 52-week high	-5.05%
Change from 52-week low	107.66%
Change from all-time high	-73.79%
Change from all-time low	107.66%
Change from open	-1.11%
Day's gap	-0.43%
Dollar volume	EUR 17,205
High price	EUR 32.34
Low price	EUR 31.98
Monthly RSI	39.37
Open price	EUR 32.34
Position in 52-week range	0%
Previous close	EUR 32.48
Price vs 150-day SMA	20.5%
Price vs 20-day SMA	5.63%
Price vs 200-day SMA	26.74%
Price vs 50-day SMA	11.97%
Relative volume	4.1
RSI	64.7
Sharpe ratio	0.44
Sharpe ratio (3Y)	-0.4
Sharpe ratio (5Y)	-0.18
Sortino ratio	0.7
Sortino ratio (3Y)	-0.42
Sortino ratio (5Y)	-0.14
Volume	538
Weekly RSI	60.59
YTD price change	15.79%
YTD total return	15.79%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	32M
Shares change (QoQ)	0%
Shares held by insiders	4.42%
Shares held by institutions	67.81%

Deeper analysis on VIE/GXI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/GXI report

Is a complete VIE/GXI research report available?

No complete published report is available for vie/GXI (VIE/GXI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/GXI (VIE/GXI)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/GXI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/GXI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/GXI

Frequently asked questions